182 related articles for article (PubMed ID: 15569992)
1. Inactivation of the FHIT gene favors bladder cancer development.
Vecchione A; Sevignani C; Giarnieri E; Zanesi N; Ishii H; Cesari R; Fong LY; Gomella LG; Croce CM; Baffa R
Clin Cancer Res; 2004 Nov; 10(22):7607-12. PubMed ID: 15569992
[TBL] [Abstract][Full Text] [Related]
2. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
4. Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor.
D'Arca D; LeNoir J; Wildemore B; Gottardo F; Bragantini E; Shupp-Byrne D; Zanesi N; Fassan M; Croce CM; Gomella LG; Baffa R
Urol Oncol; 2010; 28(2):189-94. PubMed ID: 19372053
[TBL] [Abstract][Full Text] [Related]
5. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
Liu F; Wu JZ; Li F; Li Y; Li J
Cytotherapy; 2008; 10(7):753-8. PubMed ID: 18985481
[TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
7. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
Zhang LQ; Wang H; Lai BT; Yue WT; Zhan XP; Yang XH; Zhang CY; Zhang TM
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):333-6. PubMed ID: 15949315
[TBL] [Abstract][Full Text] [Related]
8. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
10. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
Song X; Tian Z; Wang S; Peng Z; Feng J
Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
[TBL] [Abstract][Full Text] [Related]
11. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
[TBL] [Abstract][Full Text] [Related]
12. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
Hadaczek P; Siprashvili Z; Markiewski M; Domagala W; Druck T; McCue PA; Pekarsky Y; Ohta M; Huebner K; Lubinski J
Cancer Res; 1998 Jul; 58(14):2946-51. PubMed ID: 9679951
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
[TBL] [Abstract][Full Text] [Related]
14. FHIT gene expression in human urinary bladder transitional cell carcinomas.
Skopelitou AS; Gloustianou G; Bai M; Huebner K
In Vivo; 2001; 15(2):169-73. PubMed ID: 11317523
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
16. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
[TBL] [Abstract][Full Text] [Related]
17. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
18. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.
Dumon KR; Ishii H; Vecchione A; Trapasso F; Baldassarre G; Chakrani F; Druck T; Rosato EF; Williams NN; Baffa R; During MJ; Huebner K; Croce CM
Cancer Res; 2001 Jun; 61(12):4827-36. PubMed ID: 11406559
[TBL] [Abstract][Full Text] [Related]
19. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM
Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370
[TBL] [Abstract][Full Text] [Related]
20. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]